CTS Tampa has implemented the Ortho Vitros Anti-SARS-CoV-2 Total test which qualitatively detects antibody (including IgG and IgM) to SARS-CoV-2 S protein on April 20, 2020. Additionally, Vitalant Research Institute is offering the SARS-CoV-2 Reporter Viral Particle Neutralization (RVPN) test.
The situation is rapidly developing and we know you likely have many questions, but you can find all the current information here: Communications
We will be sending updates as we get more details to share with you!
On December 28, 2021, the FDA updated the emergency use authorization (EUA) for COVID-19 conva...
This is the first update to the original CTS communication distributed on July 6th. As previously co...
FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screen...
A new Learning Center website will launch on Monday, March 30, 2020. While the link to the new Learn...
As communicated on January 21, 2020, CTS will implement the licensed Grifols Babesia test for sample...
CTS Dallas and Phoenix Labs successfully implemented WNV NAT testing on the Panther Testing Platform...